In Vivo Imaging of Reactive Oxygen Species Specifically Associated with Thioflavine S-Positive Amyloid Plaques by Multiphoton Microscopy
暂无分享,去创建一个
Brian J Bacskai | B. Hyman | B. Bacskai | Bradley T Hyman | M. E. McLellan | S. Kajdasz | Stephen T Kajdasz | Megan E McLellan | M. McLellan
[1] B. Hyman,et al. Microglial response to amyloid plaques in APPsw transgenic mice. , 1998, The American journal of pathology.
[2] H. Ischiropoulos,et al. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. , 1992, Chemical research in toxicology.
[3] C. Colton,et al. Induction of Superoxide Anion and Nitric Oxide Production in Cultured Microglia a , 1994, Annals of the New York Academy of Sciences.
[4] J. Zweier,et al. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide , 1995, Nature Medicine.
[5] A. Bruce. β-Amyloid toxicity in organotypic cultures : protection by EUK-8, a synthetic catalytic free radical scavenger , 1996 .
[6] M. Mattson,et al. Aβ25–35 induces rapid lysis of red blood cells: contrast with Aβ1–42 and examination of underlying mechanisms , 1997, Brain Research.
[7] D. Perl,et al. Evidence of neuronal oxidative damage in Alzheimer's disease. , 1996, The American journal of pathology.
[8] L. Beckett,et al. Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease , 1998, Alzheimer disease and associated disorders.
[9] C. Cotman,et al. Oxidation of Aβ and Plaque Biogenesis in Alzheimer's Disease and Down Syndrome , 2001, Neurobiology of Disease.
[10] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[11] M. Mattson,et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Hasselmo,et al. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] Virginia M. Y. Lee,et al. Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis , 2001, The Journal of Neuroscience.
[14] J. Richardson,et al. Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. , 1996, Journal of neurochemistry.
[15] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[16] R J Mark,et al. Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation , 1997, The Journal of Neuroscience.
[17] M. Mattson,et al. Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal , 1997, Journal of neurochemistry.
[18] H. E. Stanley,et al. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Schwab,et al. Suppression of the oxidative burst in murine microglia by nitric oxide , 1997, Neuroscience Letters.
[20] M. Mattson. Untangling the pathophysio-chemistry of β-amyloid , 1995, Nature Structural Biology.
[21] Y. Kotake,et al. Optimal time and dosage of phenyl N-tert-butyl nitrone (PBN) for the inhibition of nitric oxide synthase induction in mice. , 1997, Free radical biology & medicine.
[22] S. Leutner,et al. Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations , 2000, Neuroscience Letters.
[23] T. Arendt,et al. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer’s disease , 2001, Brain Research.
[24] J. L. François,et al. Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer’s disease , 2001, Neuroscience.
[25] M. Mattson,et al. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. , 1994, Experimental neurology.
[26] B. Hyman,et al. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. , 2000, The American journal of pathology.
[27] C. Behl,et al. Hydrogen peroxide mediates amyloid beta protein toxicity. , 1994, Cell.
[28] B. Hyman,et al. Multiphoton microscopy and amyloid angiopathy. , 2001, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[29] M. Smith,et al. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. , 1998, The American journal of pathology.
[30] J. Growdon,et al. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.
[31] M. Baudry,et al. beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] G. Perry,et al. Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome , 2000 .
[33] M. Mattson,et al. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation , 1994, Brain Research.
[34] Mark A. Smith,et al. 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.
[35] T. Montine,et al. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. , 1997, The American journal of pathology.
[36] B. Hyman,et al. Abeta associated neuropil changes: correlation with neuronal loss and dementia. , 1998, Journal of neuropathology and experimental neurology.
[37] G. Cole,et al. Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .
[38] P Woodbury,et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.
[39] Joseph S. Beckman,et al. Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[40] G. Arendash,et al. Chronic antioxidant treatment improves the cognitive performance of aged rats , 1995, Brain Research.
[41] C. Cotman,et al. Oxidation of Abeta and plaque biogenesis in Alzheimer's disease and Down syndrome. , 2001, Neurobiology of disease.
[42] B. Hyman,et al. Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-β In Vivo by Immunotherapy , 2002, The Journal of Neuroscience.
[43] M. Beal,et al. Oxidative damage in Alzheimer's , 1996, Nature.
[44] G. Cole,et al. Vitamin E protects nerve cells from amyloid beta protein toxicity. , 1992, Biochemical and biophysical research communications.
[45] R. Floyd,et al. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Mattson,et al. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium , 1995, Brain Research.
[47] Brian J Bacskai,et al. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. , 2002, Bioorganic & medicinal chemistry letters.
[48] D. Butterfield,et al. Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.
[49] Brian J. Bacskai,et al. Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy , 2001, Nature Medicine.
[50] Yan Zhou,et al. Actions of Neurotoxic β‐Amyloid on Calcium Homeostasis and Viability of PC12 Cells Are Blocked by Antioxidants but Not by Calcium Channel Antagonists , 1996 .
[51] L. Colom,et al. Cell death induced by β-amyloid 1–40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis , 1995, Brain Research.
[52] R. Haugland,et al. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. , 1997, Analytical biochemistry.
[53] M. Mattson,et al. Secreted Forms of β-Amyloid Precursor Protein Protect Hippocampal Neurons against Amyloid β-Peptide-Induced Oxidative Injury , 1994, Experimental Neurology.
[54] G. Perry,et al. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. , 2000, Journal of neuropathology and experimental neurology.
[55] E. Masliah,et al. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. , 1990, The American journal of pathology.
[56] M. Mattson,et al. Abeta25-35 induces rapid lysis of red blood cells: contrast with Abeta1-42 and examination of underlying mechanisms. , 1997, Brain research.
[57] M. Mattson,et al. Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[58] G. Cole,et al. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.
[59] G. Arendash,et al. Antioxidant treatment with phenyl-α-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats , 1996, Neuroscience Letters.
[60] R. Floyd. Antioxidants, oxidative stress, and degenerative neurological disorders. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.